GB202202635D0 - Therapeutic antibodies - Google Patents
Therapeutic antibodiesInfo
- Publication number
- GB202202635D0 GB202202635D0 GBGB2202635.5A GB202202635A GB202202635D0 GB 202202635 D0 GB202202635 D0 GB 202202635D0 GB 202202635 A GB202202635 A GB 202202635A GB 202202635 D0 GB202202635 D0 GB 202202635D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic antibodies
- antibodies
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2202635.5A GB202202635D0 (en) | 2022-02-25 | 2022-02-25 | Therapeutic antibodies |
KR1020247001684A KR20240021959A (en) | 2021-06-17 | 2022-06-17 | Anti-canine CD20 antibody |
AU2022294198A AU2022294198A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
CN202280050529.7A CN117677637A (en) | 2021-06-17 | 2022-06-17 | Anti-canine CD20 antibodies |
BR112023026592A BR112023026592A2 (en) | 2021-06-17 | 2022-06-17 | ANTI-CANINE CD20 ANTIBODIES |
PCT/GB2022/051559 WO2022263864A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
EP22740459.7A EP4355782A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
CA3224517A CA3224517A1 (en) | 2021-06-17 | 2022-06-17 | Anti canine cd20 antibodies |
CONC2024/0000339A CO2024000339A2 (en) | 2021-06-17 | 2024-01-16 | Canine anti-cd20 antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2202635.5A GB202202635D0 (en) | 2022-02-25 | 2022-02-25 | Therapeutic antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202202635D0 true GB202202635D0 (en) | 2022-04-13 |
Family
ID=81075737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2202635.5A Ceased GB202202635D0 (en) | 2021-06-17 | 2022-02-25 | Therapeutic antibodies |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN117677637A (en) |
GB (1) | GB202202635D0 (en) |
-
2022
- 2022-02-25 GB GBGB2202635.5A patent/GB202202635D0/en not_active Ceased
- 2022-06-17 CN CN202280050529.7A patent/CN117677637A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN117677637A (en) | 2024-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202012331D0 (en) | Therapeutic antibodies | |
GB202311497D0 (en) | Therapeutic antibodies | |
GB202310818D0 (en) | Therapeutic antibodies | |
GB202300904D0 (en) | Therapeutic antibodies | |
GB202217993D0 (en) | Therapeutic antibodies | |
GB202209454D0 (en) | Therapeutic antibodies | |
GB202208544D0 (en) | Therapeutic antibodies | |
GB202202990D0 (en) | Therapeutic antibodies | |
GB202202635D0 (en) | Therapeutic antibodies | |
GB202108677D0 (en) | Therapeutic antibodies | |
GB202402048D0 (en) | Therapeutic antibodies | |
GB202402046D0 (en) | Therapeutic antibodies | |
GB202401988D0 (en) | Therapeutic antibodies | |
GB2614651B (en) | Antibodies | |
AU2023219227A1 (en) | Therapeutic antibodies | |
GB202400120D0 (en) | Anti-pgdh antibodies | |
GB202319255D0 (en) | Anti-UNC5C antibodies | |
GB202318820D0 (en) | Antibodies | |
GB202317371D0 (en) | Anti-unc5c antibodies | |
GB202317192D0 (en) | Anti-agr2 antibodies | |
GB202317189D0 (en) | Anti-AGR2 antibodies | |
GB202317188D0 (en) | Anti-AGR2 antibodies | |
GB202317187D0 (en) | Anti-AGR2 antibodies | |
GB202316016D0 (en) | Antibodies | |
GB202311473D0 (en) | Anti-ifnl1/reg3a antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |